🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Treatment for Opioid Use Disorder

Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment NCT06032559Phase 32 sites📍 New Brunswick📍 Salt Lake City Rutgers, The State University of New Jersey · Tests: MORE, SMP, TAU Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment NCT07197801NA1 site📍 Danville Geisinger Clinic · Tests: Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment NCT06323837Phase 21 site📍 Spokane Washington State University · Tests: Mirtazapine, Placebo Mindfulness Texting for Medication Adherence and Chronic Pain Management NCT07711795NA1 site📍 Albuquerque University of New Mexico · Tests: Mindfulness text messages A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098) NCT06655883Phase 313 sites📍 Garden Grove📍 New Haven📍 Bradenton Merck Sharp & Dohme LLC · Tests: Suvorexant, Placebo Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites📍 Los Angeles📍 Washington D.C.📍 Baton Rouge Montefiore Medical Center · Tests: Standard of Care Referral, Low Threshold Buprenorphine Optimization of NIBS for Treatment of Addiction NCT04379115NA3 sites📍 Hinsdale📍 Cambridge📍 Cleveland Case Western Reserve University · Tests: Active Comparator: Active tDCS + Active TUS, Sham Comparator: Sham tDCS + Sham TUS Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial NCT07439549Phase 42 sites📍 Vancouver📍 Vancouver Pouya Azar · Tests: Naloxone Hydrochloride 0.4 MG/ML, Buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablet (2… Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo Opioids, Low Nicotine Cigarettes, and Chronic Pain NCT06747871NA1 site📍 Durham Duke University · Tests: Very Low Nicotine Cigarettes (VLNC), Normal Nicotine Cigarettes (NNC) M2VA Pain Care Pathway NCT06526143NA1 site📍 West Haven Yale University · Tests: M2VA Pain Care Pathway (M2VAPCP), Implementation Facilitation A Unique, Co-Designed Family-Based Therapy NCT07587359NA1 site📍 Columbus Ohio State University · Tests: Adapted Multi-Dimensional Family Therapy, Specialty Treatment Court Program Services Optimizing Pregnancy and Treatment Interventions for Moms 3.0 NCT07586917NA1 site📍 Salt Lake City University of Utah · Tests: Patient Navigation Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices NCT07541417NA1 site📍 Greenville Prisma Health-Upstate · Tests: Certified Peer Support Specialist Intervention Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment. NCT06323824Phase 46 sites📍 Oakland📍 San Francisco📍 Denver Yale University · Tests: Methadone, Buprenorphine (BUP) Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms NCT07079215NA1 site📍 Daegu Nu Eyne Co., Ltd. · Tests: Neurostimulation, Sham stimulation Integrated Treatment for Opioid Use Disorder and PTSD NCT06641115NA1 site📍 Charleston Medical University of South Carolina · Tests: HOPE Therapy Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents NCT06732596NA1 site📍 Boston Boston Medical Center · Tests: Embodied conversational agent (ECA), Technical support, Additional ECA messages, Additional incentives Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons NCT06999811NA1 site📍 Charleston Medical University of South Carolina · Tests: Empowering Pregnant Women and People Receiving medications for opioid use disorder (EMPWR), Medication monitoring (cont… Combined THC and CBD for OUD and Chronic Pain NCT06544291Phase 21 site📍 New Haven Yale University · Tests: CBD 300mg, CBD 600mg, Placebo 0mg Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase NCT07787039NA1 site📍 Philadelphia Friends Research Institute, Inc. · Tests: STORC Focused Ultrasound for the Complex Patient NCT06453109NA1 site📍 Washington D.C. Washington D.C. Veterans Affairs Medical Center · Tests: low intensity focused ultrasound (LIFU) The Youth Opioid Recovery Support (YORS) Intervention NCT04173416NA1 site📍 Baltimore Potomac Health Foundations · Tests: Youth Opioid Recovery Support (YORS) Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention NCT06852170NA1 site📍 Eugene Chestnut Health Systems · Tests: Co-Design Sessions (CDS), Data products Opioid Adherence and Support Through Innovative Texting Strategies NCT07350148NA1 site📍 Albuquerque University of New Mexico · Tests: Mindfulness text messages Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder NCT07079826NA1 site📍 Pittsburgh Payel Roy · Tests: Sparrow Link (Active tAN), Sparrow Link (Sham tAN) Disclosure Intervention for People in Treatment for Opioid Use Disorder NCT06458985NA1 site📍 Wilmington University of Delaware · Tests: Disclosing Recovery: A Decision Aid and Toolkit Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD NCT06774248NA1 site📍 Baltimore Potomac Health Foundations · Tests: Youth Opioid Recovery Support (YORS) Ketamine for Opioid Use Disorder NCT06943859Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Treatment with Ketamine, Treatment with Very Low Dose Ketamine Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment NCT07071766NA1 site📍 Little Rock University of Arkansas · Tests: Proud of Baby and Me
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy